Biểu đồ giá cổ phiếu CLRPF
CLRPF Thu nhập
Clarity Pharmaceuticals Ltd
$1.51
-7.62%
$-0.12
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$1.51
0%
$0
Phiên trước giờ: Jun 22, 06:49:59 GMT-4
Quay lại
Clarity Pharmaceuticals Ltd (CLRPF) Thu nhập
Thống kê chính
Giá đóng cửa trước
$1.64
Giá mở cửa
$1.68
Phạm vi ngày
$1.51 - $1.68
Phạm vi 52 tuần
$1.3 - $3.6
Khối lượng
6.0K
Khối lượng trung bình
8.0K
Tỷ suất cổ tức
--
EPS (TTM)
-0.20
Vốn hóa thị trường
$565.0M
Clarity Pharmaceuticals Ltd. là gì?
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. The company is headquartered in Eveleigh, New South Wales. The company went IPO on 2021-08-25. The firm is focused on developing targeted copper theranostics based on its SAR Technology Platform. The company is progressing clinical trials with its approximately three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. Its lead product, SAR-bisPSMA, is progressing through over three clinical trials: one theranostic trial (SECuRE) and two Phase III diagnostic trials (CLARIFY and AMPLIFY). SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2). SAR-bisPSMA is developed for diagnosing, staging, and treating prostate cancer that expresses prostate-specific membrane antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer.
